World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
22420
World Ranking
15250
National Ranking
582

Ron H.J. Mathijssen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ron H.J. Mathijssen sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 752 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ron H.J. Mathijssen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ron H.J. Mathijssen sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ron H.J. Mathijssen is affiliated with Erasmus University Rotterdam in the Netherlands. Their research primarily focuses on medicine, with a substantial body of work in oncology, pulmonary and respiratory medicine, molecular biology, genetics, and cancer research.

The scientist's recent published papers include:

  • Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and Differences, 2020, Drugs
  • Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients, 2021, Circulation Research
  • Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients, 2020, Cancer Immunology Immunotherapy
  • Overt Thyroid Dysfunction and Anti-Thyroid Antibodies Predict Response to Anti-PD-1 Immunotherapy in Cancer Patients, 2020, Thyroid
  • Cross-resistance and drug sequence in prostate cancer, 2021, Drug Resistance Updates

Their frequent co-authors include:

  • Stijn L.W. Koolen (125 publications)
  • Esther Oomen-de Hoop (72 publications)
  • Anne-Marie C. Dingemans (42 publications)
  • Peter de Bruijn (39 publications)
  • Ron H. N. van Schaik (37 publications)

Publications are commonly found in the following venues:

  • Annals of Oncology (43 publications)
  • Biomedicine & Pharmacotherapy (17 publications)
  • European Journal of Cancer (13 publications)
  • Clinical Pharmacology & Therapeutics (10 publications)
  • Clinical Pharmacokinetics (10 publications)

The main fields of study encompass medicine, with focused areas in:

  • Oncology (196 publications)
  • Pulmonary and Respiratory Medicine (147 publications)
  • Molecular Biology (55 publications)
  • Genetics (45 publications)
  • Cancer Research (38 publications)

The primary research topics covered include:

  • Lung Cancer Treatments and Mutations (102 publications)
  • Cancer Immunotherapy and Biomarkers (62 publications)
  • Colorectal Cancer Treatments and Studies (62 publications)
  • Cancer Treatment and Pharmacology (62 publications)
  • Estrogen and related hormone effects (46 publications)
  • Gastric Cancer Management and Outcomes (42 publications)
  • Cancer Genomics and Diagnostics (40 publications)

Best Publications

  • Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)

    Ron H. J. Mathijssen;Robbert J. van Alphen;Jaap Verweij;Walter J. Loos

  • Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial

    Amit M Oza;David Cibula;Ana Oaknin Benzaquen;Christopher Poole

  • Effects of St. John's Wort on Irinotecan Metabolism

    Ron H. J. Mathijssen;Jaap Verweij;Peter de Bruijn;Walter J. Loos

  • Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity.

    Kelly K. Filipski;Kelly K. Filipski;Ron H. Mathijssen;Torben S. Mikkelsen;Torben S. Mikkelsen;Alfred H. Schinkel

  • Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics

    Femke M. de Man;Andrew K. L. Goey;Ron H. N. van Schaik;Ron H. J. Mathijssen

  • DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis.

    Linda M. Henricks;Carin A.T.C. Lunenburg;Femke M. de Man;Didier Meulendijks

  • Irinotecan Pathway Genotype Analysis to Predict Pharmacokinetics

    Ron H. J. Mathijssen;Sharon Marsh;Mats O. Karlsson;Rujia Xie

  • Drug–drug interactions with tyrosine-kinase inhibitors: a clinical perspective

    Roelof W F van Leeuwen;Teun van Gelder;Ron H J Mathijssen;Frank G A Jansman

  • Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs

    van Robert Leeuwen;van Robert Leeuwen;D. H. S. Brundel;C. Neef;T. van Gelder

  • Drug transporters of platinum-based anticancer agents and their clinical significance

    Herman Burger;Walter J. Loos;Karel Eechoute;Jaap Verweij

  • Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and Differences

    C. Louwrens Braal;Elisabeth M. Jongbloed;Saskia M. Wilting;Ron H. J. Mathijssen

  • ABCG2 Pharmacogenetics: Ethnic Differences in Allele Frequency and Assessment of Influence on Irinotecan Disposition

    Floris A. de Jong;Sharon Marsh;Ron H. J. Mathijssen;Cristi King

  • Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells

    Wendy Onstenk;Anieta M. Sieuwerts;Jaco Kraan;Mai Van

  • miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.

    M T M van Jaarsveld;J Helleman;A W M Boersma;P F van Kuijk

  • Pharmacogenetic Pathway Analysis for Determination of Sunitinib-Induced Toxicity

    Nielka P. van Erp;Karel Eechoute;Astrid A. van der Veldt;John B. Haanen

  • Complementary and Alternative Medicine During Cancer Treatment: Beyond Innocence

    Metin Tascilar;Floris A. de Jong;Jaap Verweij;Ron H. J. Mathijssen

  • Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancer

    R.J. van Soest;M.E. van Royen;E.S. de Morrée;J.M. Moll

  • Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein.

    Fa de Jong;TJ Scott-Horton;DL Kroetz;HL McLeod

  • Drug transporters and imatinib treatment: Implications for clinical practice

    Karel Eechoute;Alex Sparreboom;Herman Burger;Ryan M. Franke

  • Evaluation of Alternate Size Descriptors for Dose Calculation of Anticancer Drugs in the Obese

    Alex Sparreboom;Antonio C. Wolff;Ron H.J. Mathijssen;Etienne Chatelut

Frequent Co-Authors

Jaap Verweij
Jaap Verweij Erasmus University Rotterdam
Alex Sparreboom
Alex Sparreboom The Ohio State University
Stefan Sleijfer
Stefan Sleijfer Erasmus University Rotterdam
Ron H.N. van Schaik
Ron H.N. van Schaik Erasmus University Rotterdam
Hans Gelderblom
Hans Gelderblom Leiden University Medical Center
Jos H. Beijnen
Jos H. Beijnen Utrecht University
Jan H.M. Schellens
Jan H.M. Schellens Utrecht University
Henk-Jan Guchelaar
Henk-Jan Guchelaar Leiden University Medical Center
Teun van Gelder
Teun van Gelder Leiden University Medical Center
Sharyn D. Baker
Sharyn D. Baker The Ohio State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine but want flexible options, online nursing degrees offer valuable alternatives. For registered nurses wanting to advance without extensive in-person requirements, online rn to bsn programs no clinicals provide an efficient path to earning a BSN entirely online. This can be ideal for working professionals seeking advancement.

Looking to reach the highest levels in nursing? There are several dnp online programs designed for those pursuing a Doctor of Nursing Practice. Students needing to complete their doctorate on a tight schedule may benefit from accelerated dnp programs online, which significantly reduce time-to-degree for qualified applicants.

For those just starting their nursing journey, online lpn programs offer fast, flexible study options to become a Licensed Practical Nurse. These credentials lay the groundwork for entry into the medical workforce, with opportunities to continue education later. Exploring these online pathways can help you find the right fit for your goals in healthcare.

Best Scientists Citing Ron H.J. Mathijssen

Trending Scientists

Recently Published Articles